Table 4.

Cox proportional hazards model for time to death in discordant diabetic vs. non-diabetic recipient pairs

	Univariate Analysis					Multivariable Analysis*
	HR	SE	z	p-value	95% CI	HR	SE	Z	p-value	95% CI
Non-Diabetic Donor
Diabetic Recipient	1.990	0.045	30.72	< 0.001	1.905-2.080	1.932	0.063	20.20	< 0.001	1.812-2.060
Non-Diabetic Recipient	REF					REF
Diabetic Donor
Diabetic Recipient	1.847	0.156	7.24	< 0.001	1.564-2.180	1.532	0.179	3.64	< 0.001	1.218-1.927
Non-Diabetic Recipient	REF					REF
Recipient Characteristics
Age > 40	1.837	0.085	13.21	< 0.001	1.679-2.011	1.928	0.125	10.12	< 0.001	1.698-2.189
Male	1.118	0.036	3.47	0.001	1.050-1.191	1.025	0.046	0.54	0.591	0.937-1.120
African American Race	0.996	0.038	−0.12	0.907	0.924-1.072	0.954	0.052	−0.87	0.386	0.858-1.061
Pre-Transplant Dialysis**	1.058	0.006	9.30	< 0.001	1.046-1.071	1.052	0.009	5.96	< 0.001	1.035-1.070
Time on Waitlist (days)	1.000	0.000	2.85	0.004	1.000-1.000
Prior Renal Transplant	1.047	0.059	0.83	0.409	0.938-1.169	1.200	0.102	2.16	0.031	1.017-1.417
HCV+	0.647	0.228	−1.24	0.216	0.324-1.291	1.090	0.116	0.81	0.417	0.885-1.343
Max PRA ≥30	1.162	0.051	3.41	0.001	1.066-1.267
≥ 1 HLA Mismatch	1.011	0.071	0.16	0.873	0.881-1.160
Obese (BMI >=30)	1.036	0.036	1.03	0.304	0.968-1.109
Cold Ischemia Time	1.007	0.003	2.83	0.005	1.002-1.012
Delayed Graft Function	1.942	0.043	30.32	< 0.001	1.486-1.734
Acute Rejection at 1 Year	1.396	0.077	6.03	< 0.001	1.252-1.555
No Induction Immunosuppression	0.995	0.039	−0.12	0.906	0.921-1.076

^*Tacrolimus and the interaction term between tacrolimus and time were also included in the multivariable model

^**Included as an interaction term along with duration of dialysis or diabetes, as appropriate